SCHEMBL20127004

SCHEMBL20127004

CCOC(OCC)c1cc2cnc(Cl)nc2n1N1CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1995080 0.76 CCND1 (0.37)
SCHEMBL25857099 0.76 HCAR1 (0.31)
SCHEMBL4200625 0.75 KDM4E (0.31)
SCHEMBL28174161 0.75
SCHEMBL28227350 0.75
SCHEMBL24052556 0.74
SCHEMBL28294705 0.74 CCNB2 (0.31)
SCHEMBL29651155 0.73 MAT2A (0.33)
SCHEMBL24267967 0.73
SCHEMBL28175196 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10308654-B2 Preparation and use of kinase inhibitor CHANGZHOU LONGTHERA PHARMACEUTICALS INC. (CN) 2019-06-04 US disclosed
US-20180127419-A1 PREPARATION AND USE OF KINASE INHIBITOR CHANGZHOU LONGTHERA PHAMACEUTICALS INC (CN) 2018-05-10 US disclosed
US-20180127419-A1 PREPARATION AND USE OF KINASE INHIBITOR CHANGZHOU LONGTHERA PHAMACEUTICALS INC (CN) 2018-05-10 US disclosed